Safety considerations and clinical monitoring during pulsed field ablation
Europace · 2026
DOI: 10.1093/europace/euag248 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Europace, 2026. Verfasst von Pascal Defaye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Arrhythmia Department/Cardiology Department, University Hospital of Grenoble Alpes, Avenue des Maquis du Grésivaudan, CS 10217, Grenoble 38043, Franc…. Hauptthemen laut MEDLINE: Irreversible Electroporation Therapy, Monitoring, Intraoperative, Atrial Fibrillation. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boston Scientific.
Abstract (Originalsprache)
Pulsed field ablation (PFA) has emerged as a transformative technology in cardiac electrophysiology, offering a potentially superior safety profile compared with thermal ablation due to its non-thermal mechanism of irreversible electroporation. Clinical experience confirms a substantial reduction in traditional complications such as pulmonary vein stenosis, atrio-oesophageal fistula, and permanent phrenic nerve injury, though PFA introduces a distinct spectrum of physiologic effects requiring consideration. Coronary vasospasm is the most characteristic phenomenon, ranging from transient, subclinical constriction to rare ischaemic or arrhythmic events; mitigation relies on coronary anatomical awareness, optimized lesion placement, and prophylactic vasodilators. Haemolysis, caused by red blood cell electroporation, varies with catheter design and pulse burden and is typically mild, though high exposure and inadequate hydration may rarely lead to acute kidney injury. Silent cerebral lesions could result from procedural and/or energy-related factors, including gas formation, air ingress, catheter manipulation, and anticoagulation management, with uncertain long-term clinical impact but opportunities for technique-driven reduction. Interactions between PFA and cardiac implantable electronic devices are system- and context-dependent, with monopolar configurations and catheter-lead proximity influencing the risk of transient interference and rare permanent damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Arrhythmia Department/Cardiology Department, University Hospital of Grenoble Alpes, Avenue des Maquis du Grésivaudan, CS 10217, Grenoble 38043, France.
- Electrophysiology Section, Division of Cardiology, Department of Medicine, University of California San Francisco, 500 Parnassus Ave, San Francisco, CA 94143, USA.
- CCB, MVZ CCB Frankfurt und Main Taunus GbR, Markus Hospital, Wilhelm Epstein Strasse 4, Frankfurt am Main 60431, Germany.
- Centre for Heart Rhythm Disorders, Adelaide University and Royal Adelaide Hospital, Adelaide, SA, Australia.
- University Hospital Giessen, Department of Cardiology, Giessen, Germany.
- Arrhythmia and Robotic Electrophysiology Unit, La Paz University Hospital, IdiPaz, Madrid, Spain.
ORCID-Profile: Pascal Defaye, Melanie A Gunawardene, Jose L Merino, Jose M Guerra, Sandrine Venier, Savannah Bifulco, Andrea Sarkozy
Förderung
- Boston Scientific
Zitieren
APA
Defaye, P., Gerstenfeld, E. P., Gunawardene, M. A., Merino, J. L., Guerra, J. M., Venier, S., Bifulco, S., & Sarkozy, A. (2026). Safety considerations and clinical monitoring during pulsed field ablation. Europace. https://doi.org/10.1093/europace/euag248
Vancouver
Defaye P, Gerstenfeld EP, Gunawardene MA, Merino JL, Guerra JM, Venier S, et al. Safety considerations and clinical monitoring during pulsed field ablation. Europace. 2026. doi:10.1093/europace/euag248
BibTeX
@article{Defaye2026,
author = {Defaye, Pascal and Gerstenfeld, Edward P and Gunawardene, Melanie A and Merino, Jose L and Guerra, Jose M and Venier, Sandrine and Bifulco, Savannah and Sarkozy, Andrea},
title = {Safety considerations and clinical monitoring during pulsed field ablation},
journal = {Europace},
year = {2026},
doi = {10.1093/europace/euag248}
}
EUVIMED